Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LightDeck Diagnostics provides lab-quality, rapid, and quantitative point-of-care and environmental tests using its proprietary planar waveguide fluorescence immunoassay technology. The company’s platform is commercialized for veterinary diagnostics and environmental toxin monitoring, with ongoing development for human in-vitro diagnostic panels. LightDeck was acquired by Heska in January 2023 and continues to scale manufacturing and test menu expansion.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LightDeck Diagnostics.